ADAM17 and neoplasm: Compared with the selective inhibitor of ADAM10 (GI254023X), the ADAM17 inhibitors JG26 and aderbasib effectively reduced the permeability and tumor cell adhesion induced by EMT-HCT116 exosomes (Fig. 3l, m).